Severe endoscopic lesions are not associated with more infliximab fecal loss in acute severe ulcerative colitis

It has been observed that early infliximab (IFX) fecal excretion in patients with acute severe ulcerative colitis (ASUC) was associated with low treatment response.

Source: Digestive and Liver Disease - July 10, 2018 Category: Gastroenterology Authors: Florian Poullenot, Doroth ée Nivet, Stéphane Paul, Pauline Riviere, Xavier Roblin, David Laharie Tags: Correspondence Source Type: research